Management and treatment of decompensated hepatic fibrosis and severe refractory Schistosoma mansoni ascites with transjugular intrahepatic portosystemic shunt

ABSTRACT This study aimed to report the first case of a patient with hepatosplenic schistosomiasis mansoni, refractory ascites and portal vein thrombosis treated with a transjugular intrahepatic portosystemic shunt (TIPS), at the Instituto de Radiologia, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Brazil. After the procedure, the patient recovered favorably and progressed with portal pressure reduction and no deterioration of the liver function. Endovascular shunt modification is a conservative medical approach that often helps in reducing symptoms significantly, making it a less invasive and a safer alternative to liver transplantation for the treatment of schistosomiasis with portal hypertension.

[1]  H. Khara,et al.  A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy , 2021, Nutrients.

[2]  C. Cicciò,et al.  The role of diagnostic imaging and interventional radiology in liver schistosomiasis: A case report of advanced disease , 2020, Radiology of Infectious Diseases.

[3]  H. Dessein,et al.  Genetic algorithms identify individuals with high risk of severe liver disease caused by schistosomes , 2020, Human Genetics.

[4]  E. Crouchet,et al.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.

[5]  C. Zheng,et al.  Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis , 2019, CardioVascular and Interventional Radiology.

[6]  D. Garbuzenko,et al.  Current approaches to the management of patients with cirrhotic ascites. , 2019, World journal of gastroenterology.

[7]  F. Wong,et al.  An update on the pathogenesis and clinical management of cirrhosis with refractory ascites , 2018, Expert review of gastroenterology & hepatology.

[8]  R. Chung,et al.  Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  D. Blondin,et al.  Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt. , 2015, The Lancet. Infectious diseases.

[10]  Marcel Vasconcellos,et al.  Impacto do escore MELD na sobrevida de pacientes portadores de carcinoma hepatocelular, transplantados no Brasil: revisão sistemática. , 2019, Revista do Colégio Brasileiro de Cirurgiões.

[11]  J. Richter,et al.  Report of the second satellite symposium on ultrasound in schistosomiasis. , 2001, Memorias do Instituto Oswaldo Cruz.